96 related articles for article (PubMed ID: 23066917)
21. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
[TBL] [Abstract][Full Text] [Related]
22. Statins and mortality among elderly patients hospitalized with heart failure.
Foody JM; Shah R; Galusha D; Masoudi FA; Havranek EP; Krumholz HM
Circulation; 2006 Feb; 113(8):1086-92. PubMed ID: 16490817
[TBL] [Abstract][Full Text] [Related]
23. Discrepancy between results of randomized control studies and retrospective analysis: the case of statin therapy effect on one-year mortality in patients with decompensated heart failure.
Nevzorov R; Novack V; Henkin Y; Kobal SL; Jotkowitz A; Porath A
Eur J Intern Med; 2009 Sep; 20(5):494-8. PubMed ID: 19712852
[TBL] [Abstract][Full Text] [Related]
24. Temporal trends in the hospitalization and outcomes of patients with decompensated heart failure Multicenter study.
Novack V; Jotkowitz A; Porath A
Int J Cardiol; 2011 Mar; 147(2):265-70. PubMed ID: 19900727
[TBL] [Abstract][Full Text] [Related]
25. Statin-mediated low-density lipoprotein lowering in chronic congestive heart failure.
Kosmas CE; Alkhawam H; El-Hunjul M; Wagman G; Kahn MR; Grady KM; Vittorio TJ
Am J Med Sci; 2014 Jan; 347(1):14-22. PubMed ID: 23154655
[TBL] [Abstract][Full Text] [Related]
26. Effects of statin and lipoprotein metabolism in heart failure.
Miura S; Saku K
J Cardiol; 2010 May; 55(3):287-90. PubMed ID: 20350519
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
[TBL] [Abstract][Full Text] [Related]
28. Statin-induced low cholesterol is not associated with poor outcome in chronic heart failure.
Silva S; Lourenço P; Paulo C; Ferreira E; Lebreiro A; Sousa A; Mascaranhas J; Patacho M; Araujo JP; Bettencourt P
J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):284-90. PubMed ID: 22172682
[TBL] [Abstract][Full Text] [Related]
29. Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure.
Horwich TB; Hernandez AF; Dai D; Yancy CW; Fonarow GC
Am Heart J; 2008 Dec; 156(6):1170-6. PubMed ID: 19033015
[TBL] [Abstract][Full Text] [Related]
30. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
[TBL] [Abstract][Full Text] [Related]
31. Statin use in heart failure: a cause for concern?
Raina A; Pickering T; Shimbo D
Am Heart J; 2006 Jul; 152(1):39-49. PubMed ID: 16824830
[TBL] [Abstract][Full Text] [Related]
32. Low serum total cholesterol level is a surrogate marker, but not a risk factor, for poor outcome in patients hospitalized with acute heart failure: a report from the Korean Heart Failure Registry.
Yoon CH; Youn TJ; Ahn S; Choi DJ; Cho GY; Chae IH; Choi J; Cho H; Han S; Cho MC; Jeon ES; Chae SC; Kim JJ; Ryu KH; Oh BH;
J Card Fail; 2012 Mar; 18(3):194-201. PubMed ID: 22385939
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.
deGoma EM; Leeper NJ; Heidenreich PA
J Am Coll Cardiol; 2008 Jan; 51(1):49-55. PubMed ID: 18174036
[TBL] [Abstract][Full Text] [Related]
34. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy.
Wiviott SD; Cannon CP; Morrow DA; Ray KK; Pfeffer MA; Braunwald E;
J Am Coll Cardiol; 2005 Oct; 46(8):1411-6. PubMed ID: 16226163
[TBL] [Abstract][Full Text] [Related]
35. Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients.
Anker SD; Clark AL; Winkler R; Zugck C; Cicoira M; Ponikowski P; Davos CH; Banasiak W; Zardini P; Haass M; Senges J; Coats AJ; Poole-Wilson PA; Pitt B
Int J Cardiol; 2006 Sep; 112(2):234-42. PubMed ID: 16846656
[TBL] [Abstract][Full Text] [Related]
36. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
Latini R; Gullestad L; Masson S; Nymo SH; Ueland T; Cuccovillo I; Vårdal M; Bottazzi B; Mantovani A; Lucci D; Masuda N; Sudo Y; Wikstrand J; Tognoni G; Aukrust P; Tavazzi L;
Eur J Heart Fail; 2012 Sep; 14(9):992-9. PubMed ID: 22740508
[TBL] [Abstract][Full Text] [Related]
37. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
38. Drug insight: statins for nonischemic heart failure--evidence and potential mechanisms.
Lipinski MJ; Abbate A; Fuster V; Vetrovec GW
Nat Clin Pract Cardiovasc Med; 2007 Apr; 4(4):196-205. PubMed ID: 17380165
[TBL] [Abstract][Full Text] [Related]
39. In the era of the universal use of statins dyslipidemia's are still common in heart transplant recipients: a cross-sectional study.
Zakliczynski M; Boguslawska J; Wojniak E; Zakliczynska H; Ciesla D; Nozynski J; Szygula-Jurkiewicz B; Zeglen S; Zembala M
Transplant Proc; 2011 Oct; 43(8):3071-3. PubMed ID: 21996228
[TBL] [Abstract][Full Text] [Related]
40. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
